Beyond the Buzz Into the Core
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.
Rajeev Singh Raghuvanshi, the Drug Controller General of India; image credit: Vikas Dandekar Synopsis The pharmaceutical industry, and the central…
Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the…
Dr. Rajendra Achyut Badwe, Director, Tata Memorial Center. Synopsis Badwe, director of Mumbai’s Tata Memorial Centre, has reset the rules…